REDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS AFTER SWITCH FROM DUAL THERAPY TO SINGLE-INHALER TRIPLE THERAPY IN A REAL-WORLD HEALTH CARE SETTING IN THE US

被引：0
|
作者：
McCormack, Meredith C.
Noorduyn, Stephen G.
Gronroos, Noelle
Lee, Lydia
Johnson, Mary
Wrobleski, Kristin
Veeranki, Phani
Ismaila, Afisi S.
Igboekwe, Emmeline
Paczkowski, Rosirene
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3204
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4942A / 4943A
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, A.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2020, 25 : 145 - 145
  • [22] Cost-effectiveness of a Single-Inhaler Triple Therapy Versus a Dual Bronchodilator for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Australia
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Schembri, S.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Effectiveness of Switching from Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in Patients with COPD in a Real-World Setting in Japan
    Requena, Gema
    Camidge, Lucinda J.
    Ford, Alexander
    Yarita, Masao
    Hashimoto, Kenichi
    Jennison, Thomas
    Massey, Olivia S.
    Noorduyn, Stephen G.
    Mizukami, Akiko
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2025, 20 : 565 - 580
  • [24] REAL-WORLD ADHERENCE TO SINGLE-INHALER VS MULTIPLE-INHALER TRIPLE THERAPY AMONG PATIENTS WITH COPD IN A COMMERCIALLY INSURED US POPULATION
    Bogart, Michael
    Wu, Benjamin
    Germain, Guillaume
    Laliberte, Francois
    MacKnight, Sean
    Jung, Young
    Duh, Mei
    CHEST, 2020, 158 (04) : 1773A - 1774A
  • [25] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
    Olivo Neto, Pedro
    Spolidoro, Bruno Baron
    Marcolin, Gabriela
    Berton, Danilo Cortozi
    Knorst, Marli Maria
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] REAL-WORLD ADHERENCE TO SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL VERSUS MULTIPLE-INHALER TRIPLE THERAPY AMONG ASTHMA PATIENTS IN THE US
    Averell, C.
    Germain, G.
    Laliberte, F.
    MacKnight, S.
    Jung, Y.
    Duh, M. S.
    Abbott, C.
    VALUE IN HEALTH, 2021, 24 : S13 - S13
  • [28] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Slawinska, R.
    Wendt, A.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?
    Rothnie, Kieran
    Czira, Alexandrosz
    Compton, Chris
    Banks, Vicky
    Wood, Robert
    Tritton, Theo
    Thomas, Joseph
    Massey, Olivia
    Blackburn, Stuart
    Wild, Rosie
    Ismaila, Afisi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
    Trinkmann, Autoren F.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S36
12345